Adaptive Upregulation of Clumping Factor A (ClfA) by Staphylococcus Aureus in the Obese, Type 2 Diabetic Host Mediates Increased Virulence
Overview
Authors
Affiliations
Obesity and associated type 2 diabetes (T2D) are important risk factors for infection following orthopedic implant surgery. , the most common pathogen in bone infections, adapts to multiple environments to survive and evade host immune responses. Whether adaptation of to the unique environment of the obese/T2D host accounts for its increased virulence and persistence in this population is unknown. Thus, we assessed implant-associated osteomyelitis in normal versus high-fat-diet obese/T2D mice and found that infection was more severe, including increases in bone abscesses relative to nondiabetic controls. isolated from bone of obese/T2D mice displayed marked upregulation of four adhesion genes (, , , and ), all with binding affinity for fibrin(ogen). Immunostaining of infected bone revealed increased fibrin deposition surrounding bacterial abscesses in obese/T2D mice. coagulation assays demonstrated a hypercoagulable state in obese/T2D mice that was comparable to that of diabetic patients. with an inactivating mutation in clumping factor A () showed a reduction in bone infection severity that eliminated the effect of obesity/T2D, while infections in control mice were unchanged. In infected mice that overexpress plasminogen activator inhibitor-1 (PAI-1), expression and fibrin-encapsulated abscess communities in bone were also increased, further linking fibrin deposition to expression of and infection severity. Together, these results demonstrate an adaptation by to obesity/T2D with increased expression of that is associated with the hypercoagulable state of the host and increased virulence of .
A natural killer cell mimic against intracellular pathogen infections.
Ge M, Ruan Z, Zhu Y, Wu W, Yang C, Lin H Sci Adv. 2024; 10(44):eadp3976.
PMID: 39475620 PMC: 11524181. DOI: 10.1126/sciadv.adp3976.
Liu H, Liang J, Hu A Medicine (Baltimore). 2024; 103(20):e38214.
PMID: 38758842 PMC: 11098215. DOI: 10.1097/MD.0000000000038214.
Hofstee M, Siverino C, Saito M, Meghwani H, Tapia-Dean J, Arveladze S JBMR Plus. 2024; 8(2):ziad005.
PMID: 38505530 PMC: 10945728. DOI: 10.1093/jbmrpl/ziad005.
Dai J, Huang J, Wu S, Zhang F, Li Y, Rong D Foods. 2023; 12(14).
PMID: 37509743 PMC: 10378822. DOI: 10.3390/foods12142651.
Butrico C, Klopfenstein N, Green E, Johnson J, Peck S, Ibberson C Infect Immun. 2023; 91(4):e0052922.
PMID: 36877063 PMC: 10112148. DOI: 10.1128/iai.00529-22.